Pall (PLL)

Pall (PLL) Stock Quote Information

Pall Corporation manufactures and markets filtration, purification, and separation products and integrated systems solutions worldwide. The company?s Life Sciences segment offers technologies that facilitate the process of drug discovery, development, and production used in laboratories, pharmaceutical and biotechnology industries, blood centers, and hospitals at the point of patient care. It also provides medical products that enhance the safety of the use of blood products in patient care and help control the spread of infections in hospitals; and cell therapy products, which enable technologies for the regenerative medicine market. In addition, this segment sells separation systems, and disposable filtration and purification technologies used in the development and commercialization of chemically synthesized and biologically derived drugs and vaccines, as well as provides validation services to drug manufacturers, and laboratory products for use in drug discovery, gene manipulation, and proteomics applications. The company?s Industrial segment offers enabling and process enhancing technologies for various industries, such as aerospace, transportation, micro and consumer electronics, municipal and industrial water, fuels, chemicals, energy, and food and beverages. This segment also provides filters, coalescers, and integrated separation systems for hydraulic, fuel, and lubrication systems on mechanical equipment to various industries. In addition, it sells filtration and fluid monitoring equipment to aerospace industry. Further, this segment offers filtration and purification technologies for the semiconductor, data storage, fiber optic, advanced display, and materials markets, as well as a suite of contamination control solutions for chemical, gas, water, chemical mechanical polishing, and photolithography processes. The company was founded in 1946 and is based in Port Washington, New York.